Wild Biotech

Private

IsraelHealthcare & Life Scienceshttps://dbrauresults.info/online_services_students

Last Round

Series A

Oct 16, 2025

Total Funding Raised

$85.31M

Company Overview

Wild Biotech is a biotechnology company that develops an AI-powered drug-discovery platform utilizing an annotated metagenomic database of wild animal microbiota to create new medicines for inflammatory, immune, and gastrointestinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoverymicrobiome therapeuticsmetagenomicsAI drug discoveryin silico drug discoveryAI biotechgut microbiotabacteriophagesmicrobiome miningcomputational biologypreclinical researchphage therapysynthetic biologytherapeutic proteinsbiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wild Biotech Comps

Public and private peers based on sector, stage, and business model.

Wild Biotech comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wild Biotech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 16, 2025
Grant	Jun 2, 2025
Grant	Jul 1, 2022

View all Funding Rounds

Wild Biotech Investors

Notable investors and investment history

Wild Biotech investors
Investor	Rounds
Braavos Investment Advisers	Series A, Seed
Oxford Science Enterprises	Series A, Seed
University of Oxford	Series A
Advanced Research and Invention Agency	Grant
Innovate UK	Grant
Ellison Institute of Technology	Series A

View all Investors

Wild Biotech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Wild Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wild Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael

Year Founded2019

Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.